A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma

Hepatology International

Volumn 4, Issue 3, 2010, Pages 577-584

  Tangkijvanich, Pisit ^a   Sa Nguanmoo, Pattaratida ^a   Mahachai, Varocha ^a   Theamboonlers, Apiradee ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Core promoter; Enhancer II; Hepatitis B virus; Hepatocellular carcinoma; Precore; X genes

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; HEPATITIS E ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; THAILAND; VIRUS GENE; VIRUS MUTATION;

EID: 77958090656     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9197-z     Document Type: Article

References (34)

1. D Ganem AM Prince 2004 Hepatitis B virus infection-natural history and clinical consequences N Engl J Med 350 1118 1129 1:CAS:528:DC%2BD2cXitV2qurs%3D 10.1056/NEJMra031087 15014185 (Pubitemid 38298992)
2. CJ Chen MW Yu YF Liaw 1997 Epidemiological characteristics and risk factors of hepatocellular carcinoma J Gastroenterol Hepatol 12 S294 S308 1:STN:280:DyaK1c%2FntFansw%3D%3D 10.1111/j.1440-1746.1997.tb00513.x 9407350
3. A Kramvis M Kew G Francois 2005 Hepatitis B virus genotypes Vaccine 23 2409 2423 1:CAS:528:DC%2BD2MXitVCgsrc%3D 10.1016/j.vaccine.2004.10.045 15752827
4. A Kay F Zoulim 2007 Hepatitis B virus genetic variability and evolution Virus Res 127 164 176 1:CAS:528:DC%2BD2sXotVWlsL8%3D 10.1016/j.virusres.2007.02. 021 17383765 (Pubitemid 47064411)
5. CT Wai RJ Fontana 2004 Clinical significance of hepatitis B virus genotypes, variants, and mutants Clin Liver Dis 8 321 352 10.1016/j.cld.2004.02. 006 15481343 (Pubitemid 38748607)
6. ML Funk DM Rosenberg AS Lok 2002 World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants J Viral Hepat 9 52 61 1:STN:280:DC%2BD387isVGgsA%3D%3D 10.1046/j.1365-2893.2002.00304.x 11851903 (Pubitemid 36002487)
7. CH Chen CS Changchien CM Lee CH Hung TH Hu JH Wang, et al. 2008 Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study J Infect Dis 198 1634 1642 1:CAS:528:DC%2BD1cXhsFSmur3K 10.1086/592990 18939932
8. JH Kao PJ Chen MY Lai DS Chen 2003 Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers Gastroenterology 124 327 334 1:CAS:528:DC%2BD3sXhsFOhtbk%3D 10.1053/gast.2003.50053 12557138 (Pubitemid 36169249)
9. MJ Tong LM Blatt JH Kao JT Cheng WG Corey 2007 Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers Liver Int 27 1356 1363 1:CAS:528:DC%2BD1cXkvVGjtA%3D%3D 10.1111/j.1478-3231. 2007.01585.x 17900245 (Pubitemid 350142249)
10. N Shinkai Y Tanaka K Ito M Mukaide I Hasegawa Y Asahina, et al. 2007 Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2 J Clin Microbiol 45 3191 3197 1:CAS:528:DC%2BD2sXht12rurnI 10.1128/JCM.00411-07 17652471 (Pubitemid 47585639)
11. Y Tanaka M Mukaide E Orito MF Yuen K Ito F Kurbanov, et al. 2006 Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma J Hepatol 45 646 653 1:CAS:528:DC%2BD28XhtVWqtr%2FJ 10.1016/j.jhep.2006.06.018 16935384 (Pubitemid 44466666)
12. MF Yuen Y Tanaka N Shinkai RT Poon DY But DY Fong, et al. 2008 Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels Gut 57 98 102 1:CAS:528:DC%2BD1cXitVKqt78%3D 10.1136/gut.2007.119859 17483190
13. S Murakami 2001 Hepatitis B virus X protein: a multifunctional viral regulator J Gastroenterol 36 651 660 1:CAS:528:DC%2BD3MXot1Wmsro%3D 10.1007/s005350170027 11686474 (Pubitemid 33040937)
14. H Tang N Oishi S Kaneko S Murakami 2006 Molecular functions and biological roles of hepatitis B virus x protein Cancer Sci 97 977 983 1:CAS:528:DC%2BD28XhtVyltrvP 10.1111/j.1349-7006.2006.00299.x 16984372 (Pubitemid 44322542)
15. R Muroyama N Kato H Yoshida M Otsuka M Moriyama Y Wang, et al. 2006 Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma J Hepatol 45 805 812 1:CAS:528:DC%2BD28XhtFeqtLrI 10.1016/j.jhep.2006.07.025 17050029 (Pubitemid 44646684)
16. CT Yeh CH Shen DI Tai CM Chu YF Liaw 2000 Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma Oncogene 19 5213 5220 1:CAS:528:DC%2BD3cXosVOisbY%3D 10.1038/sj.onc.1203903 11077437
17. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology (Baltimore, MD) 42 1208 1236
18. K Suwannakarn P Tangkijvanich N Thawornsuk A Theamboonlers P Tharmaphornpilas P Yoocharoen, et al. 2008 Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes Hepatol Res 38 244 251 1:CAS:528:DC%2BD1cXptlWqurw%3D 10.1111/j.1872-034X.2007.00254.x 17711443 (Pubitemid 351193952)
19. P Tangkijvanich V Mahachai P Komolmit J Fongsarun A Theamboonlers Y Poovorawan 2005 Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand World J Gastroenterol 11 2238 2243 1:CAS:528:DC%2BD2MXksVymu7Y%3D 15818732
20. YC Chou MW Yu CF Wu SY Yang CL Lin CJ Liu, et al. 2008 Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma Gut 57 91 97 1:CAS:528: DC%2BD1cXitVKqtrc%3D 10.1136/gut.2006.114066 17502344
21. JK Kim HY Chang JM Lee O Baatarkhuu YJ Yoon JY Park, et al. 2009 Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma J Med Virol 81 1002 1008 10.1002/jmv.21501 19382267
22. SY Kuang PE Jackson JB Wang PX Lu A Munoz GS Qian, et al. 2004 Specific mutations of hepatitis B virus in plasma predict liver cancer development Proc Natl Acad Sci USA 101 3575 3580 1:CAS:528:DC%2BD2cXisFWmtrc%3D 10.1073/pnas.0308232100 14990795 (Pubitemid 38338237)
23. K Takahashi Y Ohta K Kanai Y Akahane Y Iwasa K Hino, et al. 1999 Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease Arch Virol 144 1299 1308 1:CAS:528:DyaK1MXls12isbs%3D 10.1007/s007050050588 10481738 (Pubitemid 29365700)
24. HI Yang SH Yeh PJ Chen UH Iloeje CL Jen J Su, et al. 2008 Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma J Natl Cancer Inst 100 1134 1143 1:CAS:528:DC%2BD1cXhtFKrsb7P 10.1093/jnci/djn243 18695135
25. LH Song DN Duy VQ Binh AJ Luty PG Kremsner CT Bock 2005 Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese J Viral Hepat 12 160 167 1:STN:280:DC%2BD2M%2Fpt1Cgsg%3D%3D 10.1111/j.1365-2893.2005.00560.x 15720531 (Pubitemid 40342174)
26. M Minami K Poussin M Kew T Okanoue C Brechot P Paterlini 1996 Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on noncirrhotic livers Gastroenterology 111 691 700 1:CAS:528:DyaK28XlvVOqt7k%3D 10.1053/gast.1996.v111.pm8780574 8780574
27. BF Chen CJ Liu GM Jow PJ Chen JH Kao DS Chen 2006 High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases Gastroenterology 130 1153 1168 1:CAS:528:DC%2BD28XksFWmurY%3D 10.1053/j.gastro.2006.01.011 16618410
28. ZL Fang CA Sabin BQ Dong LY Ge SC Wei QY Chen, et al. 2008 HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study Am J Gastroenterol 103 2254 2262 1:CAS:528:DC%2BD1cXht1OmtrzM 10.1111/j.1572-0241.2008.01974.x 18844615
29. CM Hunt JM McGill MI Allen LD Condreay 2000 Clinical relevance of hepatitis B viral mutations Hepatology 31 1037 1044 1:CAS:528: DC%2BD3cXjtlyltb0%3D 10.1053/he.2000.6709 10796877
30. SL Malmassari Q Deng H Fontaine D Houitte F Rimlinger V Thiers, et al. 2007 Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope Hepatology 45 1199 1209 1:CAS:528:DC%2BD2sXlslOju7s%3D 10.1002/hep.21594 17465004 (Pubitemid 46775783)
31. SP Hussain J Schwank F Staib XW Wang CC Harris 2007 TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer Oncogene 26 2166 2176 1:CAS:528:DC%2BD2sXjs1yqt7o%3D 10.1038/sj.onc. 1210279 17401425 (Pubitemid 46536641)
32. Koike K. Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett 2009;286:60-68
33. CH Chen CS Changchien CM Lee WC Tung CH Hung TH Hu, et al. 2009 A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan Int J Cancer 125 621 629 1:CAS:528:DC%2BD1MXmsleqt7k%3D 10.1002/ijc.24416 19431214
34. HJ Kim JH Park Y Jee SA Lee H Kim BC Song, et al. 2008 Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection J Med Virol 80 1337 1343 1:CAS:528:DC%2BD1cXptVKhsb0%3D 10.1002/jmv.21219 18551606 (Pubitemid 351897403)